MedTrace Logo

QuikClot Control+ Hemostatic Dressing Use in Mild to Moderate Bleeding

NCT04415606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2022-04-04

No results posted yet for this study

Summary

QuikClot Control+ Hemostatic Dressing (QuikClot+) is indicated for temporary control of internal organ space bleeding for patients displaying Class III or Class IV Bleeding. It may also be used for control of severely bleeding wounds such as surgical wounds and traumatic injuries. QuikClot Control+ is also indicated for temporary control of mild to moderate bleeding in cardiac surgical procedures. QuikClot Control+ is also indicated for use to control bleeding from bone surface following sternotomy.

Conditions

  • Hemostasis

Interventions

DEVICE

QuikClot Control+

Non-absorbable, sterile, X-ray detectable non-woven dressing impregnated with kaolin.

Sponsors & Collaborators

  • Z-Medica

    lead INDUSTRY

Principal Investigators

  • Mumashir Mumtaz, MD · UPMC Pinnacle

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-11
Primary Completion
2021-10-30
Completion
2021-10-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04415606 on ClinicalTrials.gov